RecruitingPhase 3NCT07413809

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Studying Multiple myeloma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Affiliated People's Hospital of Ningbo University
Principal Investigator
Peipei Ye
The Affiliated People's Hospital of Ningbo University
Intervention
Fosaprepitant(drug)
Enrollment
92 target
Eligibility
18-65 years · All sexes
Timeline
2025 – 2027

Study locations (1)

Collaborators

Zhejiang University · Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University · The Central Hospital of Lishui City · Jinhua Central Hospital · Shaoxing People's Hospital · Shaoxing Second Hospital · Jinhua People's Hospital · Zhejiang Provincial Tongde Hospital · First Affiliated Hospital of Wenzhou Medical University · Dongyang People's Hospital · Taizhou Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07413809 on ClinicalTrials.gov

Other trials for Multiple myeloma

Additional recruiting or active studies for the same condition.

See all trials for Multiple myeloma →

← Back to all trials